10 studies were found.

1.		Recruiting	Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Condition: Cancer
2.		Recruiting	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus Conditions: stage II esophageal cancer; stage III esophageal cancer; squamous cell carcinoma of the esophagus; Adenocarcinoma of the Esophagus
3.		Recruiting	Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma Conditions: Recurrent Melanoma; Stage IV Melanoma
4.		Recruiting	Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer Conditions: recurrent breast cancer; stage IV breast cancer
5.		Recruiting	Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Unresectable Brain Metastases From Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; brain metastases
6.		Recruiting	Radiation Therapy After Surgery in Treating Patients With Phyllodes Tumor of the Breast Conditions: breast cancer in situ; recurrent breast cancer; Phyllodes Tumor
7.		Recruiting	Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
8.		Recruiting	UCN-01 and Cisplatin in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
9.		Recruiting	Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer
10.		Recruiting	Vaccine Therapy in Treating Patients With Relapsed or Refractory Stage III or Stage IV Melanoma Conditions: Recurrent Melanoma; stage III melanoma; Stage IV Melanoma